New Frontiers in mRNA Cancer Therapy Researchers at Purdue University have unveiled a breakthrough platform called LENN that significantly improves the stability and targeting of messenger RNA (mRNA) therapies for bladder cancer. Described in a peer-reviewed publication and currently patent-pending, the LENN system represents a novel approach to delivering mRNA to cancer cells while minimizing…